Detalhe da pesquisa
1.
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071044
2.
Vaccine for prevention of mild and moderate-to-severe influenza in children.
N Engl J Med
; 369(26): 2481-91, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24328444
3.
A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.
BMC Infect Dis
; 14: 133, 2014 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606983
4.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847058
5.
Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study.
Lancet Infect Dis
; 20(8): 983-991, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333847
6.
Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children.
Pediatr Infect Dis J
; 38(2): 203-210, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325891
7.
A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.
Hum Vaccin
; 4(1): 60-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18376148
8.
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.
J Pediatric Infect Dis Soc
; 6(1): 9-19, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062552
9.
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
Expert Rev Vaccines
; 15(2): 201-14, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641539
10.
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.
J Pediatric Infect Dis Soc
; 5(2): 170-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407273
11.
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial.
J Pediatric Infect Dis Soc
; 4(3): 242-51, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26336604
12.
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
Vaccine
; 32(13): 1480-7, 2014 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24486352
13.
A randomized, controlled trial in children to assess the immunogenicity and safety of a thimerosal-free trivalent seasonal influenza vaccine.
Pediatr Infect Dis J
; 31(6): 605-15, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22333695
14.
Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.
J Pediatric Infect Dis Soc
; 1(1): 55-63, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687572
15.
Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
Pediatr Infect Dis J
; 30(9): e164-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21494175